🔗 Share this article

An underground market for unapproved weight-loss drugs is being driven by social media fitness personalities and vendors on communication apps, according to recent findings.

Experimental Treatment Gaining Traction Online

The experimental drug, which remains in research studies, is being advertised by social media influencers for its supposed fat-burning properties. Followers are encouraged to contact these profiles directly for source information, while also receiving discount codes.

Thriving Commerce on Messaging Platforms

Separately, a robust trade exists on messaging services, where communities with numerous of participants share comparison images, injection guides and claims of next-day British shipping. Sellers promote the substance there before redirecting buyers to WhatsApp for transactions.

Understanding The Experimental Drug

Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could help patients lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.

Healthcare Professionals Voice Worries

Nevertheless, physicians and pharmacists have cautions that the sale of what remains an unlicensed drug in the UK is a cause for concern and could result in users administering substances of unknown origin.

Several professionals stated the popularity for retatrutide could be connected to the rising price of approved slimming products such as Mounjaro.

Regulatory Position and Implementation

Marketing retatrutide on social media or Telegram is prohibited in the UK, as it is an unapproved drug that must not be promoted or distributed for human use under the Human Medicines Regulations 2012.

Several content creators attempt to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still violate medicines, marketing, and customer regulations, potentially leading to fines, prosecution or imprisonment.

Service Response and Material Removal

Based on TikTok, the service has removed violative material and prohibited related keywords and search suggestions. The company stated it was committed to keeping the platform safe and investing in strengthening enforcement strategies.

Digital Marketplace Operations

Research also discovered communities with up to nine thousand participants selling retatrutide using Telegram's built-in search feature, which operates like a public directory. Typing “retatrutide” immediately brings up groups with thousands of users, filled with photos of slimming results, glowing reviews and detailed instructions for preparing or administering at home.

After minutes of entering one community, a vendor shared contact information, where the majority of purchases occur. The vendor provided an instruction manual and guaranteed delivery within two days. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None inquired about weight, medical conditions or past usage.

Product Information and Costs

Within these communities, posts show dark colored parcels with postal service labels, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at residence with sterile water, or pre-filled pens typically priced at £160 for 20 milligrams. When questioned how long a pen should be used, vendors give conflicting responses ranging from a several days to “depends on your body”.

Platform Moderation and Security Measures

A spokesperson for the messaging service said it regularly monitored dangerous content on its platform including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are administering substances they cannot confirm. Although the research behind retatrutide is valid, these online versions may not contain what they claim,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor linked the surge in interest to current price rises for authorized weight-loss medications such as Mounjaro. “With costs increasing, individuals are using social media. But counterfeit treatments are highly dangerous. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she explained.

Her team has previously encountered individuals injured by personal administration from unverified suppliers. “We recognize the frustration, but purchasing from messaging apps or communication platforms is gambling with your well-being,” said the doctor. “These materials could be contaminated or improperly measured.”

Manufacturer Position

A spokesperson from Eli Lilly said retatrutide was in third stage research studies and had not been evaluated or approved by any government authority globally. “Therefore at this point no one can market [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a Lilly investigational product not yet authorized … may subject patients to possibly serious health risks”.